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Neural cells can be derived either from pluripotent or adult stem cells via differentiation or by transdifferen-
tiation from other cell types with the aid of tissue regulators. We compared the chromosomal stability of over
500 neural cell samples from human andmousewith virtual karyotyping (e-karyotyping).We detected notable
genomic instability in cells derived from pluripotent or adult stem cells, but surprisingly, transdifferentiated
cells seemed more chromosomally stable, except if they were reprogrammed using pluripotency factors.Differentiation intomature cells in vitro can
be achieved from pluripotent stem cells
(PSCs) and adult stem cells and also by
direct reprogramming/transdifferentiation
of one cell type into another (Ladewig
et al., 2013; Morris and Daley, 2013; Vier-
buchen and Wernig, 2012). It has recently
been shown that the reprogramming of fi-
broblasts into neural cells can be induced
by the expression of a few neural-specific
transcription factors (Vierbuchen and
Wernig, 2012). Human and mouse PSCs
may acquire large chromosomal aberra-
tions during their derivation and upon pro-
longed culturing (Ben-David and Benve-
nisty, 2012; Mayshar et al., 2010), raising
data interpretation problems and safety
concerns for future medical use of their
differentiated derivatives (Goldring et al.,
2011; Weissbein et al., 2014). However,
the genetic stability of transdifferentiated
cells has not been studied yet. Here, we
examined the chromosomal stability of
neural cells (neural stem/progenitor cells
and neurons, Table S1) that originated
from different cell types, whether by
differentiation from PSCs, differentiation
from adult stem cells, or direct conversion
from somatic cells (Morris and Daley,
2013) (Figure 1A).
Analysis of Chromosomal Stability
in Mouse Neural Cells
In order to investigate the genomic sta-
bility of mouse neural samples, we
collected gene expression data from 38
studies containing 254 samples (Table
S1 available online). To investigate thechromosomal stability of these cells, we
utilized e-karyotyping, a bioinformatic
method for analyzing chromosomal
integrity based on the regional changes
in gene expression that characterize
aneuploid cells (Ben-David and Benve-
nisty, 2012; Ben-David et al., 2011,
2013; Mayshar et al., 2010). We limited
our focus to large aberrations of whole
chromosomes or chromosome arms,
and we applied stringent criteria for sta-
tistical significance (see Supplemental
Experimental Procedures).
Of the differentiated mouse samples
derived from PSCs, 28% (24 out of 85)
showed an abnormal karyotype, and of
the samples that originated from adult
neural stem cells (NSCs), 37% (26 out of
70) contained large aberrations. Directly
differentiated cell samples, in contrast,
showed far greater stability, in that only
11% (4 out of 37) of the samples dis-
played large chromosomal aberrations.
Examples of such aberrations are shown
in Figure 1B. The analysis showed
that about one-third of all studies with
mouse neural cells had at least one aber-
rant sample. Importantly, while chromo-
somal aberrations were documented in
about 40% of the studies with adult or
PSC-derived neural cells, aberrant sam-
ples were detected in only one study in
which neural cells were generated by
transdifferentiation (Figures 1C, S1A,
and S2.)
The acquired aberrations in the mouse
PSC-derived neural samples were mainly
gains of chromosomes 8 and 11, whichCell Stem Cell 15,are known to occur during derivation and
culture adaptation of mouse PSCs (Ben-
David and Benvenisty, 2012) (Figure 1D).
In the adult NSC samples, we detected
a distinct set of aberrations that are
different from the canonical aberrations
observed in PSC-derived neural cells.
However, trisomy 19 was recurrently
observed in both types of samples, sug-
gesting that it was positively selected dur-
ing culture or differentiation of neural cells
from both pluripotent and adult stem cell
origin. In one instance of directly differen-
tiated cells, aberrations in chromosomes
1 and 11 were detected (Figures 1D,
S1A, and S2).
Analysis of Chromosomal Stability
in Human Neural Cells
Because our analysis of mouse neural
cell samples revealed a high number of
genomic aberrations, we also examined
the chromosomal integrity of human neu-
ral cells. To that end, we assembled 309
samples from 46 studies (Table S1). In hu-
man neural cells derived from PSCs, 10%
(18 out of 182) of the samples were aber-
rant. Consistently, 7% (7 out of 100) of the
samples of adult neural cells also showed
chromosomal aberrations. However, as in
the mouse, we found that the directly
differentiated cell samples were more
chromosomally stable, and we detected
only one aberration in 23 analyzed sam-
ples (Figure 2A). More broadly, we found
that one-third of the studies with human
neural cells contained at least one aber-
rant sample. From the studies with adultDecember 4, 2014 ª2014 Elsevier Inc. 687
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Figure 1. Chromosomal Aberrations inMouse Neural Cells Either Differentiated fromPluripotent and Adult StemCells or Transdifferentiated
(A) Schematic representation of the differentiation pathways into neural cells.
(B) E-karyotyping analysis of neural cells differentiated from different sources. Shown are moving average plots of representative examples for genomic
aberrations in neural cells. A gray background represents aneuploidy as recognized by the PCF algorithm.
(C) Distribution of the studies according to the samples’ source and genomic status. Each sector is labeled with the percentage of studies out of the total number
of studies, and the absolute number of studies is mentioned within brackets.
(D) Ideograms representing the chromosomal aberrations identified in mouse neural cells. Chromosomal aberrations in samples from similar cells from the same
study are interconnected by a line. Bars to the right of the chromosomes represent gains and bars to the left represent deletions.
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Synthesisor PSC-derived neural cells, we found
31% and 47% studies with at least
one aberrant sample, respectively. In
contrast, only 11% of the studies with
transdifferentiated samples (correspond-688 Cell Stem Cell 15, December 4, 2014 ª2ing to a single study) included an aberrant
sample (Figures 2B, S1B, and S2). Collec-
tively, in mouse and human, only 2 out
of 16 transdifferentiation studies had at
least one aberrant sample, compared to014 Elsevier Inc.28 out of 68 of the other studies (Fisher’s
exact test, p = 0.0265).
In the human PSC-derived neural sam-
ples, we found gains of chromosomes 1,
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Figure 2. Chromosomal Abnormalities in Human Neural Cells Either Differentiated from Pluripotent and Adult Stem Cells or
Transdifferentiated
(A) E-karyotyping analysis of human neural cells. Shown are moving average plots of representative examples for chromosomal aneuploidies in neural cells
derived from different sources. A gray background represents aneuploidy as recognized by the PCF algorithm.
(B) Distribution of the studies according to the samples’ source and genomic status. Each sector is labeled with the percentage of studies out of the total number
of studies, and the absolute number of studies is mentioned within brackets.
(C) Ideograms representing the chromosomal aberrations identified in human neural cells. Chromosomal aberrations in samples from similar cells from the same
study are interconnected by a line. Bars to the right of the chromosomes represent chromosome gain, and bars to the left represent chromosome loss.
(D) Bar plot of the percentage of aberrant samples from each source of neural cells. The transdifferentiation samples are divided by the type of the reprogramming
factors used. NF, neural factors; NF+PF, neural factors together with pluripotency factors.
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Synthesisaberrant human PSC cultures (Ben-David
et al., 2011; Mayshar et al., 2010)
(Figure 2C). Adult human NSCs and
the neurons differentiated from them
harbored aberrations that did not coincide
with the aberrations detected in human
PSC-derived neural cells, except for tri-
somy 19, observed in three independent
cases. Hence, this trisomy may provide
a selection advantage to human neural
cells, as suggested in previous studies
(Ben-David et al., 2011; Sareen et al.,
2009) (Figure 2C). Of note, although recur-
rent aberrations of chromosome 19 were
identified in both human and mouse cells,
there are no regions of synteny or homol-
ogous genes between these chromo-
somes. The directly differentiated cell
samples were found to be more stable,
with only one observed duplication
of chromosome 17 (Figures 2C, S1B,
and S2).
Reprogramming Factors Affect
Chromosomal Stability
Although we detected enhanced chromo-
somal stability in the transdifferentiated
samples, analysis of the few chromo-
somal changes observed in these sam-
ples highlights points of interest. Intrigu-
ingly, the aberrations detected included
mouse chromosome 11 and human chro-
mosome 17, the signature chromosomal
aberrations in pluripotent cells (Ben-David
and Benvenisty, 2012; Mayshar et al.,
2010), which were not detected in any
adult NSC samples. Careful analysis of
the direct reprogramming methodologies
in these cases revealed that in addition
to brain-specific transcription factors,
pluripotency genes were also utilized
(Table S2), suggesting that the cells might
have dedifferentiated into a pluripotent-
like stage prior to their neural differentia-
tion. Importantly, in both experiments
the transdifferentiation process lasted
more than 4 weeks, a sufficient time for
the aberrations to arise and fixate in the
population. In order to understand the ef-
fect of the direct differentiation technique,
we divided the samples by the factors
used, either neural factors (NFs) or neural
factors together with pluripotency factors
(NFs+PFs). This division uncovers the
importance of the reprogramming factors:
while samples reprogrammed with NFs
only always gave rise to diploid cells,
samples reprogrammed with NFs+PFs
showed the same prevalence of aberra-690 Cell Stem Cell 15, December 4, 2014 ª2tions as in adult stem-cell-derived
or PSC-derived NSCs (Figure 2D). The
mouse samples reprogrammed with only
NFs are significantly more chromosomally
stable than those differentiated from
pluripotent stem cells (Fisher’s exact
test, p = 0.00084). The human samples
showed the same trend but failed to reach
statistical significance, due to the low
number of samples reprogrammed with
only NFs. While dedifferentiation is the
most likely explanation for the elevated
risk for genomic aberrations when plurip-
otency factors are used, an alternative
explanation could be that the pluripotency
factors themselves cause stress that
somehow leads to these specific aber-
rations without prior dedifferentiation.
Future research will be required to deter-
mine between these possibilities.
Final Remarks and Conclusions
Our analysis points to chromosomal sta-
bility of transdifferentiated cells in both
human and mouse when lineage-specific
factors are used, and it emphasizes the
risk of using pluripotency factors in the
cocktail of transcription factors. The study
also highlights the high prevalence of
chromosomal aberrations in neural sam-
ples from PSCs and from adult NSCs.
A few intriguing avenues for future
research arise from our analysis. First,
our assessment of genomic instability
is most probably an underestimation,
as our study focused only on large aberra-
tions; subchromosomal aberrations, copy
number alterations, and point mutations
are undetectable by our method and are
likely to contribute to the genomic insta-
bility of these cells (Evrony et al., 2012;
McConnell et al., 2013). A definitive deter-
mination of the relative genomic stability
of transdifferentiated and stem-cell-
derived neural cells and other cell types
would require more in-depth and directed
analysis. Second, due to the relatively low
sensitivity of this method, it cannot iden-
tify aberrations that exist only in a small
fraction of the cell population (i.e., low
mosaicism levels); because transdifferen-
tiation is not a clonal event, it will be inter-
esting to study the genomic heterogeneity
within the resulting cell population. Third,
a few of the transdifferentiated cells
do not proliferate and are therefore not
subjected to selection in culture, whereas
many other differentiated neural cells
(especially NSCs) do proliferate and014 Elsevier Inc.so can gain chromosomal aberrations
due to positive selection (Ruggieri et al.,
2014). The passage number of the cells
assayed in our analysis is variable, and
formany samples it is unknown. However,
there are high-passage as well as low-
passage samples in each NSC category.
Larger data sets and better documenta-
tion of passage numbers should eventu-
ally enable us to determine how much of
the identified difference in chromosomal
stability between differentiated and trans-
differentiated neural cells can be attrib-
uted to prolonged culture propagation.
Chromosomal aberrations can signifi-
cantly alter cellular properties and may
affect the tumorigenicity of the cells
(Ben-David et al., 2014), which may
have important consequences for basic
research and regenerative medicine. Our
data emphasize the need for careful moni-
toring of neural cells derived from PSCs or
adult stem cells and suggest that transdif-
ferentiated cells may have a relative
advantage in this regard.
SUPPLEMENTAL INFORMATION
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Supplemental Experimental Procedures, two fig-
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